Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”

Quick Read

More than 40 states say the biggest drug makers engaged in “industry-wide conspiracy” to fix prices of generic drugs

Quick Read

Novartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price

Quick Read

Setting US drug prices based on prices paid in other countries could also improve affordability for Medicare beneficiaries according to a new study by researchers at Johns Hopkins, including our Michael DiStefano

Quick Read

When Matt Cronin worked in customer service at Nurx, a San Francisco start-up that sells prescription drugs online, one of his jobs was to manage the office’s inventory of birth control pills

Quick Read

Salmon on psychotropics, platypuses on prozac, and other strange tales from the wild

Quick Read

The lack of transparency puts patients at risk, some say. Institutions say disclosure could scare some people away from seeking needed medical care

Quick Read

Around 70% of inhalers used in the UK are the types that have high levels of greenhouse gases – compared to around 10% in Sweden

Quick Read